{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:02:30Z","timestamp":1773154950175,"version":"3.50.1"},"reference-count":45,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2018,8,12]],"date-time":"2018-08-12T00:00:00Z","timestamp":1534032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Data from low\u2010 and middle\u2010income countries on tumor lysis syndrome (TLS) in the pediatric population are limited. This study aims to analyze the clinical and biochemical characteristics and treatment outcomes of TLS in children with leukemia\/lymphomas in a resource\u2010limited setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Procedure<\/jats:title><jats:p>Children with intermediate risk (IRD) and high risk (HRD) for developing TLS were retrospectively studied at a tertiary cancer center in India.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Over a three\u2010year period, 224 children with acute leukemia\/lymphoma having IRD (21.8%, <jats:italic>n<\/jats:italic>\u00a0=\u00a049) and HRD (78.1%, <jats:italic>n<\/jats:italic>\u00a0=\u00a0175) were identified. TLS developed in 53.6% (<jats:italic>n<\/jats:italic>\u00a0=\u00a0120) cases, of which 75% (<jats:italic>n<\/jats:italic>\u00a0=\u00a090) had laboratory TLS alone. Thirteen children had clinical TLS (C\u2010TLS) at presentation while 17 patients progressed to develop C\u2010TLS. TLS developed in 51% (<jats:italic>n<\/jats:italic>\u00a0=\u00a025) and 54.5% (<jats:italic>n<\/jats:italic>\u00a0=\u00a095) of children with IRD and HRD, respectively. Rasburicase was used in 8.5% (<jats:italic>n<\/jats:italic>\u00a0=\u00a019) cases and five children required hemodialysis. Two children (0.8%) expired during the course of TLS management. Multivariate analysis identified the presence of hyperuricemia as the single significant risk factor for developing TLS. When children in whom a 25% change in biochemical values from the baseline that falls within the normal range were excluded, 21.4% (48\/224) cases were identified to have clinically relevant TLS (8% in IRD and 25% in HRD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>With hydration, supportive care and judicious use of rasburicase, it is feasible to manage TLS efficiently in resource\u2010limited settings. A modification of the TLS definition criteria would help to identify clinically relevant TLS.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pbc.27401","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T06:09:58Z","timestamp":1534140598000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Risk\u2010based management strategy and outcomes of tumor lysis syndrome in children with leukemia\/lymphoma: Analysis from a resource\u2010limited setting"],"prefix":"10.1002","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6589-379X","authenticated-orcid":false,"given":"Kaduveettil Gopinathan","family":"Gopakumar","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology Regional Cancer Centre  Trivandrum Kerala India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2343-988X","authenticated-orcid":false,"given":"Shwetha","family":"Seetharam","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology Regional Cancer Centre  Trivandrum Kerala India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6393-6357","authenticated-orcid":false,"given":"Jagathnath Krishna","family":"KM","sequence":"additional","affiliation":[{"name":"Department of Cancer Epidemiology and Biostatistics Regional Cancer Centre  Trivandrum Kerala India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjusha","family":"Nair","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology Regional Cancer Centre  Trivandrum Kerala India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2667-1625","authenticated-orcid":false,"given":"Binitha","family":"Rajeswari","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology Regional Cancer Centre  Trivandrum Kerala India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9245-2060","authenticated-orcid":false,"given":"Guruprasad","family":"CS","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology Regional Cancer Centre  Trivandrum Kerala India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanth","family":"VR","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology Regional Cancer Centre  Trivandrum Kerala India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8332-8391","authenticated-orcid":false,"given":"Priyakumari","family":"Thankamony","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology Regional Cancer Centre  Trivandrum Kerala India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,8,12]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90174-N"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05094.x"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03150312"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.6751"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0177"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.3816\/SCT.2005.n.008"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.88"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13403"},{"key":"e_1_2_9_10_1","first-page":"273","article-title":"Tumor lysis syndrome","volume":"13","author":"Arrambide K","year":"1993","journal-title":"Semin Nephrol"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950180405"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1989.tb11163.x"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(86)80387-0"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.1974.11713785"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-016-0971-3"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-200501000-00005"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv317"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr490"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.6.806"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2004.09.004"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705379"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D111"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.01013.x"},{"key":"e_1_2_9_24_1","first-page":"91","article-title":"Single dose rasburicase in the management of tumor lysis syndrome in childhood acute lymphoblastic leukemia: a case series","volume":"25","author":"Latha SM","journal-title":"Indian J Nephrol"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08143.x"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0904569"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.995"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000054661"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-036665"},{"key":"e_1_2_9_30_1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00277-003-0608-2","article-title":"Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma\/leukemia before and after introduction of prophylactic use of urate oxidase","volume":"82","author":"W\u00f6ssmann W","year":"2003","journal-title":"Ann Hematol"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf134"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155214520821"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403566"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.02.378"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428190903456959"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500404662"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11575"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00860751"},{"key":"e_1_2_9_39_1","first-page":"504","article-title":"Metabolic emergencies in clinical oncology","volume":"16","author":"Silverman P","year":"1989","journal-title":"Semin Oncol"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.10.2998"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11612"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402235"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.115"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P296"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01457.x"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-009-0402-6"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.27401","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.27401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T16:11:10Z","timestamp":1694794270000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.27401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1002\/pbc.27401"],"URL":"https:\/\/doi.org\/10.1002\/pbc.27401","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,12]]},"assertion":[{"value":"2018-01-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e27401"}}